✦ LIBER ✦

Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairment

✍ Scribed by Paul Statkevich, Teddy Kosoglou…

Book ID: 120759269
Publisher: Springer
Year: 2012
Tongue: English
Weight: 199 KB
Volume: 68
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-012-1269-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

✍ Kosoglou, Teddy; Kraft, Walter K.; Kumar, Bharath; Statkevich, Paul; Xuan, Fengj 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 221 KB

Pharmacodynamics and pharmacokinetics of

Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects

✍ Teddy Kosoglou; Larisa Reyderman; Renger G. Tiessen; André A. van Vliet; Robert 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 504 KB

PAR-1 ANTAGONIST VORAPAXAR IMPROVES GLOB

PAR-1 ANTAGONIST VORAPAXAR IMPROVES GLOBAL THROMBOTIC STATUS IN PATIENTS WITH CORONARY DISEASE

✍ Gorog, Diana A.; Christopoulos, Christos; Niespialowska-Steuden, Maria N.; Kozar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 145 KB

PAR-1 antagonist vorapaxar favorably imp

PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease

✍ Rosser, G.; Tricoci, P.; Morrow, D.; Christopoulos, C.; Niespialowska-Steuden, M 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 228 KB

Vorapaxar, an oral PAR-1 receptor antago

Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics and pharmacodynamics of warfarin

✍ Kosoglou, Teddy; Zhu, Yali; Xuan, Fengjuan; Black, Laura; Johnson-Levonas, Amy O 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 227 KB

The pharmacokinetics of escitalopram in

The pharmacokinetics of escitalopram in patients with hepatic impairment

✍ Johan Areberg; Jacob Strøyer Christophersen; Mette Nøhr Poulsen; Frank Larsen; K 📂 Article 📅 2006 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 285 KB